Woodcliff Lake, NJ, February 2, 2014 – Eisai Inc. announced today that the Phase 3…
Read More
From the American Thyroid Association: In collaboration with the Food and Drug Administration (FDA), and…
AstraZeneca is pleased to announce two new clinical trials for patients with differentiated thyroid cancer….
Bayer and Onyx Pharmaceuticals Announce FDA Priority Review Designation of Nexavar® (sorafenib) Supplemental New Drug…
The ATA is pleased to confirm the launch of the ATA Corporate Information & Opportunities webpage which includes a link to the ATA corporate online news submission form.
AMERICAN THYROID ASSOCIATION® , ATA® , THYROID® , CLINICAL THYROIDOLOGY® , and the distinctive circular logo are registered in the U.S. Patent and Trademark Office as trademarks of the American Thyroid Association® , Inc.